Publications by authors named "Reinhard Angermann"

Claim this Profile
S
Systemic counterregulatory response of angiopoietin-2 after intravitreal injections with faricimab for nAMD.
Anna Lena Huber, Angelika Bauer, Julius Beirer, Katharina Frede, Katharina Kirchmair, Reinhard Angermann

Graefes Arch Clin Exp Ophthalmol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Faricimab maintains substance integrity and sterility after compounding and storage in two different polypropylene syringe types.
Alexander Taschauer, Arthur Sedivy, Daniel Egger, Reinhard Angermann, Haider Sami

Eye (Lond)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progerin mRNA Is Associated with Smoking and Signs of Increased Microvascular Damage in Patients with Diabetic Macular Edema.
Marc-Michael Zaruba, Reinhard Angermann, Simon Staggl, Vivek Jeyakumar, Sofia Mair

Int J Mol Sci· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of the COVID-19 Pandemic on the Quality of Care of Treatment-Naïve Patients with Neovascular Age-Related Macular Degeneration Receiving Intravitreal Aflibercept.
Reinhard Angermann, Alexander Franchi, Katharina Frede, Julia Rettenwander, Tanja Rettenwander

Klin Monbl Augenheilkd· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal layer thinning as a biomarker of long-term disability progression in multiple sclerosis.
Klaus Berek, Harald Hegen, Jakob Hocher, Michael Auer, Franziska Di Pauli, Reinhard Angermann

Mult Scler· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term persistence with aflibercept therapy among treatment-naïve patients with exudative age-related macular degeneration in a universal health care system: a retrospective study.
Reinhard Angermann, Alexander Franchi, Katharina Frede, Victoria Stöckl, Christoph Palme

BMC Ophthalmol· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal Aflibercept Therapy and Treatment Outcomes of Eyes with Neovascular Age-Related Macular Degeneration in a Real-Life Setting: A Five-Year Follow-Up Investigation.
Reinhard Angermann, Alexander Franchi, Victoria Stöckl, Julia Rettenwander, Tanja Rettenwander

Ophthalmol Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of compliance among patients with diabetic macular oedema treated with intravitreal aflibercept: a 48-month follow-up study.
Reinhard Angermann, Markus Hofer, Anna Lena Huber, Teresa Rauchegger, Yvonne Nowosielski

Acta Ophthalmol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CHANGES IN SYSTEMIC LEVELS OF VASCULAR ENDOTHELIAL GROWTH FACTOR AFTER INTRAVITREAL INJECTION OF AFLIBERCEPT OR BROLUCIZUMAB FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Reinhard Angermann, Anna Lena Huber, Yvonne Nowosielski, Stefan Salcher, Thomas Gasser

Retina· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficiency benchmarks in the surgical management of primary rhegmatogenous retinal detachment: a monocentric register cohort study of operating room time metrics and influential factors.
Reinhard Angermann, Anna Lena Huber, Markus Hofer, Yvonne Nowosielski, Stefan Egger

BMJ Open· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration.
Anna Lena Huber, Reinhard Angermann, Yvonne Nowosielski, Christof Seifarth, Martina T Kralinger

J Ophthalmol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bilateral cataract surgery improves neurologic brake reaction time and stopping distance in elderly drivers.
Yvonne Nowosielski, Benedikt Leitner, Teresa Rauchegger, Reinhard Angermann, Angeliki Psomiadi

Acta Ophthalmol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic counterregulatory response of angiopoietin-2 after aflibercept therapy for nAMD: a potential escape mechanism.
Reinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, Christof Seifarth, Stefan Egger

Acta Ophthalmol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of COVID-19 protective measures on the ophthalmological patient examination with an emphasis on gender-specific differences.
Teresa Rauchegger, Antonia Osl, Yvonne Nowosielski, Reinhard Angermann, Christoph Palme

BMJ Open Ophthalmol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of submacular fluid volume on visual outcome in macula-off rhegmatogenous retinal detachment using automated optical coherence tomography volumetric quantification.
Reinhard Angermann, Stefan Mosböck, Christoph Palme, Hanno Ulmer, Teresa Rauchegger

Clin Exp Ophthalmol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two-year outcomes of minimally invasive XEN Gel Stent implantation in primary open-angle and pseudoexfoliation glaucoma.
Teresa Rauchegger, Reinhard Angermann, Peter Willeit, Eduard Schmid, Barbara Teuchner

Acta Ophthalmol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Patient Mobility and Journey Distance as Risk Factors for Severe Visual Impairment: Real-Life Data Analysis of Treatment-naïve Patients with nAMD under Intravitreal Aflibercept Therapy].
Teresa Rauchegger, Reinhard Angermann, Anja Meusburger, Jana Schwab, Gertrud Haas

Klin Monbl Augenheilkd· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Ocular Nocardiosis: A Case Report.
Reinhard Angermann, Martin Stattin, Claus Zehetner

Ocul Immunol Inflamm· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Timing on Visual Outcomes in Fovea-Involving Retinal Detachments Verified by SD-OCT.
Reinhard Angermann, Nikolaos E Bechrakis, Teresa Rauchegger, Marina Casazza, Yvonne Nowosielski

J Ophthalmol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment compliance and adherence among patients with diabetic retinopathy and age-related macular degeneration treated by anti-vascular endothelial growth factor under universal health coverage.
Reinhard Angermann, Teresa Rauchegger, Yvonne Nowosielski, Marina Casazza, Angelika Bilgeri

Graefes Arch Clin Exp Ophthalmol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Triamcinolone in small-gauge vitrectomy for epiretinal membrane peeling.
Reinhard Angermann, Claus Zehetner, Patrick Sidoroff, Inga Waltl, Gerhard Kieselbach

Can J Ophthalmol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Intravitreal Aflibercept on Galectin-1 and Vascular Endothelial Growth Factor-A Plasma Levels in Patients with Diabetic Retinopathy.
Inga Waltl, Claus Zehetner, Christof Seifarth, Florian Handle, Gerhard F Kieselbach, Reinhard Angermann

Curr Eye Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis